Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis

INTRODUCTION: We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses. We aimed to assess the effectiveness of MSC to impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrahin, Aliaksandr, Jenkins, Helen E., Hurevich, Henadz, Solodovnikova, Varvara, Isaikina, Yanina, Klimuk, Dzmitri, Rohava, Zoya, Skrahina, Alena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894747/
https://www.ncbi.nlm.nih.gov/pubmed/27284577
http://dx.doi.org/10.1016/j.jctube.2016.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894747/
https://www.ncbi.nlm.nih.gov/pubmed/27284577
http://dx.doi.org/10.1016/j.jctube.2016.05.003

Ejemplares similares